Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Conjupro Biotherapeutics, Inc.
Filamon LTD
Atavistik Bio, Inc
PMV Pharmaceuticals, Inc
AstraZeneca
University of California, Davis
OHSU Knight Cancer Institute
University of Michigan Rogel Cancer Center
Alterome Therapeutics, Inc.
National Institutes of Health Clinical Center (CC)
Rutgers, The State University of New Jersey
Eli Lilly and Company
UMC Utrecht
BeOne Medicines
Aveni Foundation
Monte Rosa Therapeutics, Inc
Psyence Australia Pty Ltd
ViroMissile, Inc.
University of Virginia
Dana-Farber Cancer Institute
Case Comprehensive Cancer Center
National Institutes of Health Clinical Center (CC)
Novartis
Duke University
Washington University School of Medicine
University of Florida
AstraZeneca
Tizona Therapeutics, Inc
University of Florida
Essen Biotech
Essen Biotech
Leiden University Medical Center
MBrace Therapeutics
Hospital Moinhos de Vento
Clasp Therapeutics, Inc.
Columbia University
Eli Lilly and Company
Angiex, Inc.
Sapience Therapeutics
IDEAYA Biosciences
Ottawa Hospital Research Institute
Memorial Sloan Kettering Cancer Center
Institut du Cancer de Montpellier - Val d'Aurelle